Buradasınız

Mesanenin değişici epitel hücreli karsinomlannda AgNOR ve mitotik indeks yöntemlerinin tümör grade'i ile ilişkisi

To compare of AgNOR and MI methods in transiüonal celi carcinoma of urinary bladder and to study correiation between tumor grade

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
This study was designed to compare AgNOR and MI methods which are known as proliferation indexes in transitionai celi carcinoma of urinary bladder (TCCJ and to study correiation and regression between grade and AgNOR and MI methods. At the same time we aimed to identify any threshold valve which could help determıne grade and prog-nosis. İn this study, 102 cases ofTCC were involved which were diagnosed between 2000 and 2003 in the Pathology Department of Meram Medical Faculty, Selçuk University. As control group, thirthy eystitis cases vvhose epitheiia were normal in the surface apperance were chosen. Microscopic features of the cases were retrospectively re-evaluated in the iight of latest literatüre. To grade TCC cases we chose the system proposed by Ash. Cases were re-evaluated ınde-pendently of their previous diagnoses. Stainıng and counting systems proposed for AgNOR by Crocker were used vvhen counting AgNOR spots, spots stained black with si/ver in the nucleolus (AgNOR 1} and those both in nucleus and nucleolus (AgNOR llj vvere counted, for each case, in 100 celis vvithout noticing size and distribution. When per-forming Mi method proposed by Simpson. we calculated possible celi and mitosis counts in ten different microscop¬ic areas. The number obtained by a ratio of total mitosis count to possible celi count was accepted as Mi and denom-inator was expressed as 1000. We have found thatAgNOR and Mi values inereased associating grade of the tumor. We could demonstrate a correiation between MI and grade though there was not such a correiation.
Abstract (Original Language): 
Bu çalışma mesanenin Değişici Epitel Hücreli Karsinom (DEHKj tanısı alan olgularında proliferatif belirleyiciler olan AgNOR ve Mitotik İndeks (MI) yöntemlerini karşılaştırmayı, grade ile korelasyon ve regresyonunu incelemeyi, grade'in tespitinde ve prognoz hakkında kesin yorumda bulunmayı mümkün kılacak bir eşik değerin bulunup bulunamaya¬cağını araştırmak amacı ile planlandı. Bu amaçla Selçuk Üniversitesi Meram Tıp Fakültesi Patoloji Anabilim Dalı'nda 01 Ocak 2000 ve 31 Ocak 2003 tarihleri arasında mesanenin DEHK tanısı alan 102 olgu çalışmada kullanıldı. Ayrıca kont¬rol grubu amacıyla, yüzey epiteli normal görünümdeki, sistit tanısı almış olan 30 olgu çalışmaya dahil edildi. DEHK tanısı almış olguların yeniden grade'lenmesî için Ash'ın önerdiği sistem esas alındı ve eski tanılarından bağımsız olarak yeniden değerlendirildi. AgNOR yöntemi için Crocker'ın önerdiği boyama ve sayım sistemi kullanıldı. AgNOR benek¬lerini sayarken 100 hücrede gümüş ile siyah boyanmış nükleolus içindeki AgNOR benekleri (AgNOR ij ile nükleolus içi + nükleus içi AgNOR benekleri (AgNOR 11} sayıldı. Simpson'un önerdiği MI yöntemini uygularken MI: mitoz/ tahmini hücre sayısı sonucu elde edilen değer payda 1000 olacak şekilde ifade edildi. Mesanenin DEHK'larında grade arttıkça ortalama AgNOR ve MI değerlerinin arttığı, fakat Mi ile arasında anlamlı bir ilişki bulunmadığı görüldü.
66-73

REFERENCES

References: 

1. Johnson DE, Svvanson DA Von Eschenbach AC. Tumors of genitourinary tract. İn: Tanagho EA Mc Aninch _IW. ed Smith's general urology. I2th ed. Appleton 8: Lange, Lebanon, 1988; 33.
2. Catron RS, Kumar V, Robbıns SL Pathologic basış of dısease The lower urinary tract. 5 th ed. Philadelphia: W.B Saunders Company. 1994; 991-1005.
3. Nochomovitz I_E. Bladder biopsy interpretation. First Edition. NewYork: Raven Proj 1992; 73 -126.
4. Witjes JA Kiemeny LA Ooester GO, Debruyne FM. Prognostic factors in superficial Bladder cancer. Eur Urol 1992; 21.89-97.

5. Vıctor ER, Mayron RM. The lovver urinary tract. İn:
Stephan S. Sternberg ed. Diagnostic surgical pathoiogy.
New York: Raven Proj, 1994; 1778-85. 6 Rosai J. Ackerman's surgical pathoiogy: Urinary tract. 7th
ed. St. Louis: The C.V. Mosby Company, 1989; 898-917. 7. Crocker J, Boldy DAR, Egan MJ. How should we count
AglMORs: Proposals for astandardızed approach. J Pathol
1989;158:185-8. 8 Peterson RO. Urologic pathoiogy. Urinary bladder.2th ed
Philadelphia: JB Lippincott Company. 1992. 260-395. 9. Simpson JF, Dutt PL, Page DL. Expession of mitosis per
thousand celi and celi density in breast carcinomas. Hum
Pathol 1992. 23 608-1 I.

. Lipponen PK, Eskelinen MJ, Jauhıamen K. Grading of superficial bladder cancer by quantitative mitotic freuquency analysis. J Urol 1993; 149:36-41.
1 1. Hılsenbeck SG, Alired DC. Universıty of Texas Health Science Center at San Antonla. Improved methods of esti-mating mitotic activity in solid tumors. Editorial. Hum Pathol. 38. Van Diest PJ, Baak JAP. Matzecok P. Wisse-Brekelmans BSC Reproducubiiity of mitosis counting in 2469 breast cancer specimens; Results from the muiticen-ter Morphometric marnmary carcinoma project. Hum Pathol 1992; [23): 601-2.
12. Van Diest PJ. Baak JAP, Matzecok P. Wisse-Brekelmans BSC. Reproducubiiity of mitosis counting in 2469 breast cancer specimens: Results from the multicenter Morphometric marnmary carcinoma project. HumPathof 1992; 23: 603-7.
13. Catalona WJ. Bladder cancer. İn: Gillenwater JY, Grayhack JT, Howards SS, Duckets JYV (Editors).Adult and pediatric urology. 2th ed. Mosby-Year book. İne; 1994,1 135-83.
14. Lucien EN, Nabila EM. The renal pelvis, ureter, urinary Bladder and urethra. İn: Silverberg SG, ed. Principles and praetica of surgical pathoiogy. New York: Churthıl! Livingstone, 1990; 1485-1512.
15. Cohen MB, Waldman FM, Carrol PR, Kerschmann R Comparison of five histopathologic methods to assess cel-lular proliferation in transitional celi carcinoma of the uri¬nary bladder. Hum Pathol 1993;24:772-8.
16. Bozlu M, Orhan D, Baltacı S, Yaman O, Elhan AH, Tulunay O, Müftüoglu YZ. The prognostic value of proliferating celi antigen, Kİ-67 and nucleolar organizer region in transi¬tional celi carcinoma of the bladder. Int Urol Nephrol 2002;33(l);59-66.
I 7. Johnson GC, Miller MA, Ramos-Vara JA Comparısion of argyrophilic nucleolar organizer regions (AgNORs) and mitotic index ın distinguishing benign from malignant canine smooth muscle tümör and in separating inflam-matory hyperplasia from neoplastic lesions of the urinary bladder mucosa. J Vet Diagn Invest J 995,7(1); 127-36.
18. Tomobe M, Shimazui T, Uchida K, Akaza H. AgNOR count in resting cells [resting NOR) is a new prognostic marker in invasive bladder tumor. Anal Celi Pathol 2001;22(4); 193-9.
19. Menon MM, Simha M. Celi adhesion molecule E-cadherin and cellular proliferation marker AgNOR in bladder lesions-usefulness and limitatıons. Indian J Cancer. 1998;35(4J; 142-6.
20. Akpolat I. Barış YS, Yılmaz AF. Bakırtaş M, Saylık A Karagöz F; Kandemir B Cathepsin B, p53 expression and AgNORs in transitional celi carcinoma. Neoplasma 1998; 4 5 (6)3 6 5-8.
21. Skopelitou A, Korkolopoulou P. Papanİcoiaou A. Christodoulou P, Thomas-Tsagli E, Pavlakis K. Comparative assessment of proliferating celi nuclear anti¬gen immonostaining and of nucleolar organizer region staining in transitional celi carcinomas of the urinary blad¬der. Correiation with other conventional prognostic pathologic parameters. Eur Urol 1992;22(3);235-40.
22. Zambelli S, Zanin A Gaglio A Zai G, Bosco E, Andrion A Magnani C. Ki-67 scores and AgNOR counts in transition¬al celi carcinoma of the bladder: apparent lack of prog¬nostic value. Arch Ital Urol Androl I993;65(6];665-70.

23. Koyuncuoglu M, Kargı A Cingöz S. Kırkalı Z. Investigation of p53, c-erbB-2, PCNA immunoreactivity. DNA content, AgNOR and apoptosis in bladder carcinoma as prognos¬tic parameters. Cancer Lett. 1998; 24; 126(2); 143-8
24. Crocker J, Boldy DAR, Egan MJ. How should we count AgNORs Proposals for astandardızed approach. J Pathol 1989;158:185-8.
25. Heney NM, Ahrned S, F MJ. Frable W, Corder MP, Haferman MD. Superficial bladder cancer: Progression and recurrens. 3 Urol 1983; 130: 1083-6.
26. Griffiths AP, Butler CW, Roberts P. Sılver stained struetures (AgNORs). Their dependence on tissue fixatıon and abss of prognostic relevanc in reetai adenocarcinoma. J. Pathol 1989;159:121-7.
27 Ruschoff J. Zimmermann R, Ulshofer B. Thomas C. Silver-stained nucleolar organizer proteins in urethelial bladder lesions. Path Res Pract 1992;( 188):593-8.
28. Korneyev A Mamaev NfM, Kozlov W, Rybakova, MG, al-Shukri SH. Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional celi bladder tumours. Mol Pathol 2000; 54(3):200.
29. Skopelitou A. Korkolopoulou P, Papanİcoiaou A. Comparative assessmentof proliferating celi nuclear anti¬gen immunostaining and of nucleolar organizer region staining in transitional celi carcinomas of the urinary bladder. Eur Urol 1992; 22: 235-40.
30. Martin H, Hufnagl P, Wenzelides K, Beıl M. AgNORs in celi of urothelial carcinoma of the bladder. A quantıtative study using automatic microscopic image analysis Zentralbl Pathol. 1991; 137(6];505-9.
31. Simpson JF. Dutt PL and Page DL. Expession of mitosis per thousand celi and celi density inbreast carcinomas. Hum Pathol 1992, 23 608-1 I.
32. Lipponen PK. Eskelinen MJ, Jauhiarnen K. Grading of superficial bladder cancer by quantıtatıve mitotic freuquency analysis. J Urol 1993; 149:36-41.
33. Donhuijsen K, Schimidt U. Hirehe H. Changes in mitotic rate and celi eyele fraetions caused by delayed fixation. HumPathol 1990;21:709-14.
34. Hail PA Levison DA. Revievv: Assessment of celi prolifera¬tion in histological material. J. Clin Pathol 1990;43:!84-92.
35. Oınn CM, Wrighy NA Revievv article. The clinical assess¬ment of proliferation and grovvth in human tumours: Evaluation of methods and applications as prognostic variables. J Pathol 1990;160:93-102.
36. Avunduk MC, Tekin Ş, Tavlı Ş. Memenin infiltratif duktal karsinomlannda P53. östrojen reseptör proteini. PCNA ve Kİ-67 ekspresyonu ile AgNOR indeksi özelliklerinin araştırılması. S. Ü. Tıp Fak Derg 1999;15:53-7.
37. Lipponen PK, Eskelinen MJ, Nordling S. Relationship betvveen DNA flow eytometric data, nuclear morfometric variables and volume-corrected mitotic index m transitio¬nal celi bladder tumors. Eur Urol 1991; 19:327-3 I.
38. Lipponen PK., Eskelinen MJ. and Sotarauta M. Prediction of superficial bladder cancer by histoquantitative met¬hods. Eur J Cancer 1990;26:1060-3.

Thank you for copying data from http://www.arastirmax.com